Northern Trust Corp Nymox Pharmaceutical Corp Transaction History

Northern Trust Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.46 - $2.48 $543,038 - $922,421	-371,944 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$2.22 - $3.39 $64,186 - $98,015	-28,913 Reduced 7.21%	371,944 $826,000
Q4 2020 Feb 11, 2021	BUY	$1.84 - $2.83 $3,137 - $4,825	1,705 Added 0.43%	400,857 $994,000
Q3 2020 Nov 16, 2020	SELL	$2.3 - $3.66 $20,194 - $32,134	-8,780 Reduced 2.15%	399,152 $982,000
Q2 2020 Aug 14, 2020	BUY	$2.1 - $4.6 $856,657 - $1.88 Million	407,932 New	407,932 $1.45 Million
Q3 2019 Nov 13, 2019	SELL	$1.41 - $2.12 $369,914 - $556,184	-262,351 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$1.33 - $2.12 $27,173 - $43,313	-20,431 Reduced 7.23%	262,351 $381,000
Q1 2019 May 13, 2019	BUY	$1.57 - $2.71 $8,203 - $14,159	5,225 Added 1.88%	282,782 $557,000
Q4 2018 Feb 12, 2019	BUY	$1.31 - $2.53 $7,894 - $15,245	6,026 Added 2.22%	277,557 $363,000
Q3 2018 Nov 14, 2018	SELL	$2.46 - $3.7 $3,183 - $4,787	-1,294 Reduced 0.47%	271,531 $668,000
Q2 2018 Aug 14, 2018	BUY	$3.12 - $4.33 $68,103 - $94,515	21,828 Added 8.7%	272,825 $916,000
Q1 2018 May 09, 2018	BUY	$3.09 - $4.43 $15,996 - $22,934	5,177 Added 2.11%	250,997 $1.06 Million
Q4 2017 Feb 14, 2018	SELL	$3.29 - $4.06 $19,049 - $23,507	-5,790 Reduced 2.3%	245,820 $812,000
Q3 2017 Nov 13, 2017	BUY	$3.36 - $4.02 $845,409 - $1.01 Million	251,610	251,610 $962,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.